Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Second Opinion Laboratory IVS
IVS
Bankrupt
CVR 38502697
Marielundvej 32B, 1.
Sundhedsvæsen i øvrigt i.a.n. · NACE 869090
Est. 2017
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2020
DKK -114
-145% vs 2019
EBITDA margin
100.0%
-145% vs 2019
Equity ratio
15.1%
Financial strength
Net profit 2020
DKK -114
-157% vs 2019
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2017
0M
0%
2018
0M
0%
2019
0M
0%
2020
Key figures
Annual report 2020
Revenue
DKK -114
-145%
EBITDA
DKK -114
-145%
Net profit
DKK -114
-157%
Total assets
DKK 2K
-6%
Equity
DKK 351
-25%
Employees
—
—
Company information
Legal name
Second Opinion Laboratory IVS
CVR number
38502697
Legal form
Iværksætterselskab
NACE code
869090 · Sundhedsvæsen i øvrigt i.a.n.
Founded
13. marts 2017
Share capital
DKK 1
Employees
—
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Contact
Address
Marielundvej 32B, 1.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Sundhedsvæsen i øvrigt i.a.n.
Companies in Herlev
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2017
0M
2018
0M
2019
0M
2020
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2017
0M
2018
0M
2019
0M
2020
Income statement
DKK thousands
Item
2017
2018
2019
2020
Revenue
0
0
0
-0
Staff expenses
-0
-0
-0
-0
EBITDA
0
0
0
-0
Depreciation & amort.
-0
-0
-0
-0
EBIT
0
0
0
-0
Net financials
0
0
0
0
Profit before tax
0
0
0
-0
Tax
-0
0
0
-0
Net profit
0
0
0
-0
Balance sheet
DKK thousands
Item
2017
2018
2019
2020
Total assets
2
2
2
2
Equity
0
0
0
0
Long-term debt
0
0
0
0
Short-term debt
2
2
2
2
Total debt
2
2
2
2
Financial ratios
5-year trend
EBITDA margin
-11400.0%
This company
15.8%
Market median
-72252% vs market
2017
2020
Equity ratio
15.1%
This company
38.2%
Market median
-60% vs market
2017
2020
Return on equity
-32.5%
This company
18.4%
Market median
-277% vs market
2017
2020
Net profit margin
-11400.0%
This company
8.1%
Market median
-140841% vs market
2017
2020
Asset turnover
-0.05×
This company
1.12×
Market median
-104% vs market
2017
2020
Debt / equity
5.62×
This company
0.62×
Market median
-806% vs market
2017
2020
Annual reports & filings
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
View
PDF
Annual report 2017
Filed via CVR / Virk · Period 2017-03-13 – 2017-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
LS
Lars Skanvig Bramhelft
Unofficial title
Unofficial title
2022
—
—
JJ
Jesper John Anhøj
Chief Executive Officer
Chief Executive Officer
2017
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Rådgivnings Enheden S.M.B.A.
Company
100.0%
100.0%
2017
Second Opinion Clinics Eftf. IVS
Company
100.0%
100.0%
2018
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Second Opinion Laboratory IVS also hold positions in
0
other companies.
Person
Role here
Other companies
Lars Skanvig Bramhelft
Unofficial title
0 companies
Jesper John Anhøj
Chief Executive Officer
0 companies